UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medipost hits record vial sales for Cartistem
by Lee Han-soo
2017-11-30 16:16
Biopharmaceutical firms' liver treatments draw attention
by So Jae-hyeon
2017-11-30 12:02
What are doctors’ views on Invossa used even by foreign patients?
by Lee Hye-seon
2017-11-29 09:31
Green Cross, Feldan start joint tech development
by Lee Han-soo
2017-11-27 16:59
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed
by Nam Doo-hyun
2017-11-27 13:13
라인
Biogen Korea taps new CEO
by Marian Chu
2017-11-27 11:57
Clinical trials on CAR-T cell therapies surge in two years
by Nam Doo-hyun
2017-11-24 15:53
Kolon okayed for clinical trial to expand treatment for Invossa-K injection
by Lee Han-soo
2017-11-23 15:53
GemVax & KAEL confirms potential tracer effective to reperfusion injury
by Constance Williams
2017-11-22 15:51
COGIB spotlights future of innovative biotherapeutic
by Lee Han-soo
2017-11-22 11:06
라인
KAEL confirms potential tracer as treatment for kidney cancer
by Constance Williams
2017-11-20 15:44
Samsung Bioepis wins European sales approval for Ontruzant
by Lee Han-soo
2017-11-20 10:48
ViroMed aims phase 1 trial on CAR-T cell therapy by 2020-2022
by Nam Doo-hyun
2017-11-17 13:53
Earthquake hits biopharmaceutical factories in Pohang
by Nam Doo-hyun
2017-11-16 15:55
J&J struggles to maintain market dominance of Remicade
by Lee Han-soo and Nam Doo-hyun
2017-11-16 10:25
라인
Hugel merges with subsidiaries
by Lee Han-soo
2017-11-15 17:51
Macrogen reaffirms diagnostic sequencing capability with CAP certification
by Constance Williams
2017-11-15 14:48
Janssen drops suit against Samsung Bioepis on Renflexis
by Lee Han-soo
2017-11-14 17:59
Celltrion to test combo therapy of new flu antibody drug, Tamiflu
by Lee Hye-seon
2017-11-14 11:38
Biopharmaceutical firms rank high in Kosdaq market cap
by Nam Doo-hyun
2017-11-13 15:25
-
이전
21
22
23
24
25
26
27
28
29
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top